Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 82, Issue 3, 2008, Pages 329-334

  Foss Freitas, M C ^a   Foss, N T ^a   Donadi, E A ^a   Foss, M C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Glycemic control; Intracellular staining; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; CD3 ANTIGEN; CD33 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD CELLS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 55549148380     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.003     Document Type: Article

References (22)

1. Valssara H., Brownlee M., Manogue K.R., Dinarello C.A., and Pasagian A. Cachectin TNF- and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240 (1988) 1546-1548
2. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
3. UKPDS Research Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
4. Foss N.T., Polon D.P., Takada M.H., Foss-Freitas M.C., and Foss M.C. Skin lessions in diabetic patients. Rev. Saúde Pública 34 (2005) 677-682
5. Joshi N., Caputo G.M., Weitekamp M.R., and Krachmer A.W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 16 (1999) 1906-1912
6. Shah B.R., and Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26 (2003) 510-513
7. Saeed F.A., and Castle G.E. Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infection. Clin. Diag. Lab. Immunol. 5 (1998) 740-743
8. Delamaire M., Maugendre D., Moreno M., Le Goff M.C., Allannic H., and Genetet B. Impaired leucocyte function in diabetic patients. Diabet. Med. 14 (1997) 29-34
9. Mahmoud A.A., Rodman H.M., Mandel M.A., and Warren K.S. Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunological responses. J. Clin. Invest. 57 (1976) 362-367
10. Foss-Freitas M.C., Foss N.T., Donadi E.A., and Foss M.C. Effect of the metabolic control on the in vitro proliferation of peripheral blood mononuclear cells in type 1 and type 2 diabetic patients. São Paulo Med. J. 124 4 (2006) 219-222
11. Foss-Freitas M.C., Foss N.T., Donadi E.A., and Foss M.C. In vitro TNF-α and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann. N. Y. Acad. Sci. 1079 (2006) 177-180
12. Foss-Freitas M.C., Foss N.T., Donadi E.A., and Foss M.C. Effect of the metabolic control on interferon-γ and interleukin-10 production peripheral blood mononuclear from type 1 and type 2 diabetic patients. Braz. J. Med. Biol. Res. 40 5 (2007) 671-677
13. Geerlings S.E., and Hoepelman A.I.M. Immune dysfunction in patients with diabetes mellitus. FESM Immunol. Med. Microbiol. 26 (1999) 259-265
14. Moutschen M.P., Scheen A.J., and Lefebvre P.J. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabet. Med. 18 (1992) 187-201
15. Dandona P., Aljada A., and Mohant P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45 (2002) 924-930
16. Foss M.C., Foss N.T., Pacolla G.M.C.F., and Silva C.L. Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz. J. Med. Biol. Res. 25 (1992) 239-242
17. Pickup J.C., Chusney G.D., Thomas S.M., and Burt D. Plasma interleukin-6, tumor necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci. 67 (2000) 291-300
18. van de Pouw-Kraan T., de Jong R., and Arden L. Development of human Th1 and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur. J. Immunol. 23 (1993) 1-5
19. Andesson U., Andersson J., Lindfors A., Wagner K., Möller G., and Heusser C.H. Simultaneous production of interleukin 2, interleukin 4, interferon-γ by activated human blood lymphocytes. Eur. J. Immunol. 20 (1990) 1591-1596
20. Mocellin S., Marincola F., Rossi C.R., Nitti D., and Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 15 (2004) 61-76
21. Geelings S.E., Brouwer E.C., van Kessel K.C.P.M., Gaastra W., Stolk R.P., and Hoepelman A.I.M. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 30 (2000) 995-1001
22. Esposito K., Nappo F., Giugliano F., Di Palo C., Ciotola M., Barbieri M., et al. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care 26 (2003) 1647